×
Request Free Sample ×
Chronic Disease Management Market Research Report - Forecast till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Chronic Disease Management Market

ID: MRFR/HC/0475-HCR
200 Pages
Rahul Gotadki
February 2026

Chronic Disease Management Market Research Report: Size, Share, Trend Analysis By Product Type - (Software, On-premise, Cloud-based, Web-based, Services), By Disease Indication - (Diabetes, Cardiovascular Disease, Respiratory Disease, Cancer, Chronic Kidney Disease, Others), By Application - (Remote patient monitoring (RPM) platforms, Mobile health (mHealth) apps, Predictive analytics & population health dashboards, Patient engagement tools, Others applications), By End Use (Healthcare Providers, {Hospitals & Clinics, Primary Care Networks}, Healthcare Payers) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2026 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Chronic Disease Management Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Chronic Disease Management Market Summary

As per MRFR analysis, the Chronic Disease Management Market Size was estimated at 9.29 USD Billion in 2025. The Chronic Disease Management industry is projected to grow from 10.54 USD Billion in 2026 to 37.14 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 13.42 during the forecast period 2026 - 2035.

Key Market Trends & Highlights

The Chronic Disease Management Market is experiencing a transformative shift towards integrated and personalized care solutions.

  • The integration of digital health solutions is reshaping chronic disease management practices across various healthcare settings.
  • North America remains the largest market, while the Asia-Pacific region is emerging as the fastest-growing area for chronic disease management.
  • Remote patient monitoring continues to dominate the market, whereas telehealth services are rapidly gaining traction among consumers.
  • The rising prevalence of chronic diseases and technological advancements in healthcare are driving market growth and innovation.

Market Size & Forecast

2025 Market Size 9.29 (USD Billion)
2035 Market Size 37.14 (USD Billion)
CAGR (2026- 2035) 13.51%

Major Players

UnitedHealth Group (US), Anthem (US), Cigna (US), CVS Health (US), Humana (US), Aetna (US), Kaiser Permanente (US), Mayo Clinic (US), Teladoc Health (US), McKesson Corporation (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Chronic Disease Management Market Trends

The Chronic Disease Management Market is currently experiencing a transformative phase, driven by the increasing prevalence of chronic conditions and the growing demand for effective management solutions. Healthcare providers are increasingly adopting innovative technologies and integrated care models to enhance patient outcomes. This shift appears to be influenced by a heightened awareness of the importance of proactive health management, which encourages patients to engage more actively in their care. Furthermore, the integration of telehealth services and digital health tools is reshaping the landscape, allowing for more personalized and accessible care options. In addition, the Chronic Disease Management Market is witnessing a surge in collaborative efforts among stakeholders, including healthcare providers, technology companies, and policymakers. These collaborations seem to focus on developing comprehensive strategies that address the multifaceted challenges associated with chronic disease management. As a result, there is a growing emphasis on preventive care, patient education, and the utilization of data analytics to inform decision-making. This evolving environment suggests that the market is poised for continued growth, with an increasing number of solutions aimed at improving the quality of life for individuals living with chronic diseases.

Integration of Digital Health Solutions

The integration of digital health solutions into chronic disease management is becoming increasingly prevalent. This trend indicates a shift towards utilizing mobile applications, wearable devices, and telehealth platforms to monitor patient health and facilitate communication between patients and healthcare providers. Such technologies may enhance patient engagement and adherence to treatment plans.

Focus on Personalized Care

There is a growing emphasis on personalized care within the Chronic Disease Management Market. This trend suggests that healthcare providers are increasingly tailoring treatment plans to meet the unique needs of individual patients. By leveraging data analytics and patient feedback, providers may offer more effective interventions that align with patients' specific health profiles.

Collaborative Care Models

Collaborative care models are gaining traction as a means to improve chronic disease management. This trend indicates a movement towards interdisciplinary teams working together to provide comprehensive care. By fostering collaboration among various healthcare professionals, these models may enhance the overall quality of care and improve patient outcomes.

Chronic Disease Management Market Drivers

Aging Population

The aging population is a critical driver of the Global Chronic Disease Management Market Industry. As individuals age, the likelihood of developing chronic diseases increases, necessitating effective management strategies. By 2035, the global population aged 60 years and older is expected to reach 1.4 billion, which will likely exacerbate the demand for chronic disease management solutions. This demographic shift compels healthcare systems to adapt and invest in tailored programs that address the unique needs of older adults. Consequently, the market is anticipated to grow at a CAGR of 5.19% from 2026 to 2035, reflecting the increasing focus on geriatric care.

Market Growth Projections

The Global Chronic Disease Management Market Industry is poised for substantial growth, with projections indicating a market value of 40 USD Billion by 2035. This anticipated growth is underpinned by a compound annual growth rate (CAGR) of 5.19% from 2026 to 2035. Various factors, including the rising prevalence of chronic diseases, technological advancements, and supportive government policies, are expected to drive this upward trajectory. The market's expansion reflects a broader recognition of the need for effective chronic disease management solutions that can enhance patient quality of life and reduce the burden on healthcare systems.

Growing Awareness and Education

Increasing awareness and education regarding chronic diseases are vital factors propelling the Global Chronic Disease Management Market Industry. Public health campaigns and educational programs are effectively informing individuals about the importance of early detection and management of chronic conditions. This heightened awareness encourages patients to seek timely medical intervention and adhere to prescribed treatment regimens. As a result, healthcare providers are witnessing an uptick in demand for chronic disease management services. The ongoing emphasis on patient education is likely to foster a more proactive approach to health, thereby contributing to the overall growth of the market.

Government Initiatives and Policies

Government initiatives aimed at improving healthcare access and quality are pivotal to the Global Chronic Disease Management Market Industry. Various countries are implementing policies that promote preventive care and chronic disease management programs. For example, the Centers for Medicare & Medicaid Services in the United States have introduced initiatives to enhance care coordination for patients with chronic conditions. Such policies not only aim to reduce healthcare costs but also improve patient outcomes. As governments continue to prioritize chronic disease management, the market is expected to expand, driven by increased funding and support for innovative healthcare solutions.

Rising Prevalence of Chronic Diseases

The Global Chronic Disease Management Market Industry is experiencing growth due to the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders. As of 2025, the market is valued at approximately 22.9 USD Billion, reflecting a heightened demand for effective management solutions. The World Health Organization indicates that chronic diseases account for nearly 71% of all deaths globally, underscoring the urgent need for comprehensive management strategies. This trend is likely to drive investments in innovative healthcare technologies and services aimed at improving patient outcomes and reducing healthcare costs.

Technological Advancements in Healthcare

Technological innovations are significantly influencing the Global Chronic Disease Management Market Industry. The integration of telemedicine, wearable devices, and mobile health applications facilitates real-time monitoring and management of chronic conditions. For instance, remote patient monitoring systems have shown to enhance patient engagement and adherence to treatment plans. As healthcare providers increasingly adopt these technologies, the market is projected to grow, potentially reaching 40 USD Billion by 2035. This shift towards digital health solutions not only improves patient access to care but also streamlines healthcare delivery, thereby addressing the complexities associated with chronic disease management.

Market Segment Insights

By Application: Remote Patient Monitoring (Largest) vs. Telehealth Services (Fastest-Growing)

In the Chronic Disease Management Market, Remote Patient Monitoring (RPM) holds the largest share, primarily driven by its ability to enhance patient engagement and ensure continuous monitoring of chronic conditions. This segment's growth is bolstered by rising chronic disease prevalence coupled with technical advancements that facilitate better health outcomes. Telehealth Services, while currently a smaller segment, are rapidly gaining traction, reflecting increased demand for remote consulting due to convenience and access, making it the fastest-growing area in the market.

Remote Patient Monitoring (Dominant) vs. Telehealth Services (Emerging)

Remote Patient Monitoring is recognized as the dominant force within the Chronic Disease Management sector, characterized by its significant adoption across various healthcare settings. It enables healthcare providers to monitor patients' vital statistics and adherence to treatment regimens in real time, reducing the need for frequent hospital visits. On the other hand, Telehealth Services are emerging as a vital solution for increasing access to care, especially in remote areas; their growth is largely attributed to the shift toward value-based care and the increasing comfort level of both patients and providers with virtual consultations. The evolving regulatory framework and investment in telecommunication technologies are expected to further propel this segment's growth.

By Disease Type: Diabetes (Largest) vs. Cardiovascular Diseases (Fastest-Growing)

The Chronic Disease Management Market exhibits a diverse distribution among its various disease types. Diabetes remains the largest segment, commanding a significant share due to the global rise in obesity and sedentary lifestyles. Following closely is cardiovascular diseases, which has witnessed increased awareness and diagnosis, contributing to its growing prominence in the market. Chronic respiratory diseases, cancer, and neurological disorders also make significant contributions, but they trail behind the leading segments in terms of market share.

Diabetes (Dominant) vs. Neurological Disorders (Emerging)

Diabetes is the dominant force in the Chronic Disease Management Market, primarily driven by its prevalence and the increasing incidence of lifestyle-related conditions. Effective management strategies, including insulin therapy and continuous glucose monitoring, have elevated the importance of this segment. In contrast, neurological disorders represent an emerging area within the market, gaining traction due to growing awareness and advancements in treatment options. The rise in neurodegenerative diseases' diagnoses showcases the need for dedicated management solutions. Both segments reflect the complexities of chronic disease management, with diabetes leading the charge while neurological disorders expand their footprint.

By End User: Healthcare Providers (Largest) vs. Patients (Fastest-Growing)

The Chronic Disease Management Market exhibits a diverse set of end users, with Healthcare Providers commanding the largest share. This segment encompasses hospitals, clinics, and ancillary care facilities that play a crucial role in delivering chronic disease management services. In recent years, the demand for integrated care solutions has led to sustained growth for this group, positioning them as key stakeholders in the market landscape. Conversely, Patients represent the fastest-growing segment, fueled by increased awareness and self-management initiatives. With the rise of digital health tools and telemedicine, more patients are actively participating in their own care. This shift not only empowers individuals but also transforms traditional care delivery models, emphasizing the critical role of patient engagement in chronic disease management strategies.

Healthcare Providers (Dominant) vs. Patients (Emerging)

Healthcare Providers stand as the dominant force within the Chronic Disease Management Market, with their extensive networks and expertise shaping treatment protocols. These entities are increasingly integrating technology into their practice, leveraging data analytics and patient management systems to improve care quality and outcomes. As they adapt to evolving healthcare paradigms, they're recognizing the importance of coordinated care models. In contrast, Patients, classified as the emerging segment, are leveraging new technological advancements such as mobile health applications and telehealth services. This empowerment shift is leading to a more collaborative approach to disease management, where patients take the initiative in their care, thus redefining the dynamics between providers and patients. The interplay between these two groups is critical for advancing chronic disease management.

By Delivery Mode: Cloud-based Solutions (Largest) vs. Mobile Applications (Fastest-Growing)

The Chronic Disease Management Market shows a diverse landscape in terms of delivery modes, with cloud-based solutions capturing the largest share. These solutions provide flexible accessibility and enhanced data management capabilities, making them a preferred choice among healthcare providers. On-premise solutions remain significant for organizations prioritizing data security, while wearable devices and integrated platforms are also crucial segments, catering to varying needs within chronic disease management.

Cloud-based Solutions (Dominant) vs. Mobile Applications (Emerging)

Cloud-based solutions are recognized as the dominant delivery mode in the Chronic Disease Management Market due to their ability to streamline patient data and enhance communication between healthcare providers and patients. They allow for real-time analytics and data accessibility, which is essential for effective disease management. In contrast, mobile applications are emerging as a powerful tool, enabling patients to engage actively with their health management through tracking, reminders, and telehealth services. The growth of mobile technology and increasing smartphone penetration are fueling the rapid adoption of these applications, making them a vital component for future developments.

Get more detailed insights about Chronic Disease Management Market
Request Free Sample

Regional Insights

North America : Market Leader in Healthcare Innovation

North America is poised to maintain its leadership in the Chronic Disease Management Market, holding a significant market share of 4.65 billion in 2025. Key growth drivers include an aging population, increasing prevalence of chronic diseases, and advancements in telehealth technologies. Regulatory support, such as the Affordable Care Act, has catalyzed the expansion of healthcare services, enhancing access and affordability for patients. The competitive landscape is dominated by major players like UnitedHealth Group, Anthem, and Cigna, which are leveraging technology to improve patient outcomes. The U.S. is the leading country, with a robust healthcare infrastructure and a focus on integrated care models. The presence of innovative companies like Teladoc Health and Mayo Clinic further strengthens the market, driving investment in chronic disease management solutions.

Europe : Emerging Market with Growth Potential

Europe's Chronic Disease Management Market is projected to grow significantly, with a market size of 2.8 billion in 2026. Key growth drivers include an increasing burden of chronic diseases, supportive government policies, and a shift towards value-based care. The European Union's initiatives to enhance healthcare accessibility and quality are pivotal in shaping the market landscape, fostering innovation and collaboration among stakeholders. Leading countries such as Germany, France, and the UK are at the forefront of this growth, with a competitive landscape featuring key players like Cigna and Aetna. The region is witnessing a rise in digital health solutions, which are essential for managing chronic conditions effectively. As healthcare systems evolve, the focus on integrated care models is expected to enhance patient outcomes and reduce healthcare costs.

Asia-Pacific : Rapidly Growing Healthcare Sector

The Asia-Pacific region is experiencing rapid growth in the Chronic Disease Management Market, projected to reach $1.7 billion by 2026. Factors driving this growth include rising urbanization, increasing healthcare expenditure, and a growing awareness of chronic disease prevention. Governments are implementing policies to enhance healthcare infrastructure, which is crucial for managing chronic diseases effectively. Countries like China and India are leading the charge, with a burgeoning population and increasing demand for healthcare services. The competitive landscape features both local and international players, including CVS Health and Humana, who are investing in innovative solutions to cater to the diverse needs of the population. The focus on telemedicine and digital health is transforming the way chronic diseases are managed in this region.

Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa (MEA) region is gradually developing its Chronic Disease Management Market, with a size of $0.14 billion in 2026. Key growth drivers include increasing healthcare investments, a rising prevalence of chronic diseases, and government initiatives aimed at improving healthcare access. However, challenges such as limited healthcare infrastructure and varying regulatory environments hinder rapid growth. Countries like South Africa and the UAE are making strides in enhancing healthcare services, with a focus on chronic disease management. The competitive landscape is still evolving, with local players and international companies exploring opportunities in this underserved market. As healthcare systems mature, the emphasis on integrated care and patient education will be crucial for improving health outcomes in the region.

Chronic Disease Management Market Regional Image

Key Players and Competitive Insights

The Chronic Disease Management Market is currently characterized by a dynamic competitive landscape, driven by the increasing prevalence of chronic diseases and the growing demand for integrated care solutions. Major players such as UnitedHealth Group (US), Cigna (US), and Teladoc Health (US) are strategically positioning themselves through innovation and digital transformation. UnitedHealth Group (US) focuses on leveraging data analytics to enhance patient outcomes, while Cigna (US) emphasizes personalized care management programs. Teladoc Health (US) is at the forefront of telehealth services, expanding its reach through strategic partnerships, which collectively shape a competitive environment that prioritizes patient-centric solutions and technological advancements.Key business tactics within this market include optimizing supply chains and localizing service delivery to enhance accessibility. The competitive structure appears moderately fragmented, with a mix of large established players and emerging startups. This fragmentation allows for diverse approaches to chronic disease management, as companies strive to differentiate themselves through unique service offerings and innovative care models.
In November UnitedHealth Group (US) announced a partnership with a leading AI firm to develop predictive analytics tools aimed at improving chronic disease management. This strategic move is likely to enhance their ability to anticipate patient needs and tailor interventions accordingly, thereby improving health outcomes and reducing costs. Such initiatives underscore the importance of technology in driving efficiency and effectiveness in chronic disease management.
In October Cigna (US) launched a new digital platform designed to streamline care coordination for patients with multiple chronic conditions. This platform integrates various health services, enabling a more holistic approach to patient care. The strategic significance of this launch lies in its potential to reduce fragmentation in care delivery, ultimately leading to better patient experiences and outcomes.
In September Teladoc Health (US) expanded its telehealth services to include specialized chronic disease management programs, targeting conditions such as diabetes and hypertension. This expansion reflects a growing trend towards virtual care solutions, which are increasingly favored by patients seeking convenience and accessibility. The strategic importance of this move is evident in its alignment with the broader shift towards digital health solutions, which are becoming essential in managing chronic diseases effectively.
As of December current competitive trends in the Chronic Disease Management Market are heavily influenced by digitalization, AI integration, and a focus on sustainability. Strategic alliances are increasingly shaping the landscape, as companies recognize the value of collaboration in enhancing service offerings. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technology, and supply chain reliability, as organizations strive to meet the complex needs of chronic disease patients.

Key Companies in the Chronic Disease Management Market include

Industry Developments

  • Q2 2024: Omada Health Raises $73 Million to Expand Digital Chronic Disease Management Market Platform Omada Health announced a $73 million funding round to accelerate the expansion of its digital platform for chronic disease management, focusing on diabetes, hypertension, and musculoskeletal conditions.
  • Q2 2024: Teladoc Health Launches New Chronic Care Solution for Employers Teladoc Health introduced a new integrated chronic care management solution aimed at large employers, combining virtual care, remote monitoring, and personalized coaching for conditions such as diabetes and hypertension.
  • Q2 2024: Philips Receives FDA Clearance for Next-Gen Remote Patient Monitoring Platform Royal Philips received FDA clearance for its next-generation remote patient monitoring platform, designed to support chronic disease management for patients with heart failure, COPD, and diabetes.
  • Q2 2024: DarioHealth Partners with Sanofi to Expand Digital Chronic Disease Management Market DarioHealth announced a strategic partnership with Sanofi to co-develop and commercialize digital solutions for chronic disease management, targeting diabetes and cardiometabolic conditions.
  • Q3 2024: Livongo Founder Launches New Startup Focused on AI-Driven Chronic Disease Management Market The founder of Livongo launched a new startup leveraging artificial intelligence to deliver personalized chronic disease management programs, initially targeting diabetes and hypertension.
  • Q3 2024: Cigna Expands Chronic Disease Management Market Services with New Virtual Care Platform Cigna announced the launch of a new virtual care platform to enhance its chronic disease management services, offering remote monitoring and digital coaching for members with chronic conditions.
  • Q3 2024: UnitedHealth Group Acquires Chronic Care Management Startup for $350 Million UnitedHealth Group completed the acquisition of a digital chronic care management startup, aiming to integrate its technology into UnitedHealthcare’s care management programs.
  • Q4 2024: Medtronic Launches New Connected Insulin Pen for Diabetes Management Medtronic launched a new connected insulin pen in the U.S. market, designed to improve diabetes management through real-time data sharing and integration with chronic disease management platforms.
  • Q4 2024: ResMed Acquires Chronic Disease Telehealth Provider for $200 Million ResMed announced the acquisition of a telehealth provider specializing in chronic disease management, expanding its digital health portfolio for patients with sleep apnea and COPD.
  • Q1 2025: CVS Health Opens New Digital Health Hub for Chronic Disease Management Market CVS Health opened a new digital health hub focused on chronic disease management, offering virtual consultations, remote monitoring, and personalized care plans for patients with multiple chronic conditions.
  • Q1 2025: Humana Launches AI-Powered Platform for Proactive Chronic Disease Intervention Humana launched an AI-powered platform designed to identify and intervene with members at risk of chronic disease complications, aiming to reduce hospitalizations and improve outcomes.
  • Q2 2025: Kaiser Permanente Announces $100 Million Investment in Chronic Disease Digital Tools Kaiser Permanente announced a $100 million investment to develop and deploy new digital tools for chronic disease management, focusing on remote monitoring and patient engagement.

Future Outlook

Chronic Disease Management Market Future Outlook

The Chronic Disease Management Market is projected to grow at a 13.51% CAGR from 2026 to 2035, driven by technological advancements, increasing prevalence of chronic diseases, and rising healthcare expenditures.

New opportunities lie in:

  • Development of AI-driven patient monitoring systems Expansion of telehealth platforms for chronic care Integration of wearable health technology in disease management

By 2035, the market is expected to be robust, reflecting substantial growth and innovation.

Market Segmentation

Chronic Disease Management Market End User Outlook

  • Healthcare Providers
  • Patients
  • Payers
  • Pharmaceutical Companies
  • Technology Vendors

Chronic Disease Management Market Application Outlook

  • Remote Patient Monitoring
  • Telehealth Services
  • Medication Management
  • Data Analytics
  • Patient Education

Chronic Disease Management Market Disease Type Outlook

  • Diabetes
  • Cardiovascular Diseases
  • Chronic Respiratory Diseases
  • Cancer
  • Neurological Disorders

Chronic Disease Management Market Delivery Mode Outlook

  • Cloud-based Solutions
  • On-premise Solutions
  • Mobile Applications
  • Wearable Devices
  • Integrated Platforms

Report Scope

MARKET SIZE 2025 9.29(USD Billion)
MARKET SIZE 2026  10.54(USD Billion)
MARKET SIZE 2035 37.14(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 13.51% (2026 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2025
Market Forecast Period 2026 - 2035
Historical Data 2019 - 2025
Market Forecast Units USD Billion
Key Companies Profiled UnitedHealth Group (US), Anthem (US), Cigna (US), CVS Health (US), Humana (US), Aetna (US), Kaiser Permanente (US), Mayo Clinic (US), Teladoc Health (US), McKesson Corporation (US)
Segments Covered Application, Disease Type, End User, Delivery Mode
Key Market Opportunities Integration of digital health technologies enhances patient engagement in the Chronic Disease Management Market.
Key Market Dynamics Rising demand for personalized treatment solutions drives innovation in chronic disease management technologies and services.
Countries Covered North America, Europe, APAC, South America, MEA

Market Highlights

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch
Leave a Comment

FAQs

What is the projected growth of the Chronic Disease Management market?

The Chronic Disease Management market is the expected increase in total market value of 37.14 USD billion over a defined forecast period 2026 –2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

What is the size of the Chronic Disease Management market?

Chronic Disease Management market size was valued at approximately 9.29 billion USD in 2025. This figure will reach 37.14 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

What is the CAGR of the Chronic Disease Management market?

Chronic Disease Management market is expected to grow at a CAGR of 13.51% between 2026 and 2035.

How much will the Chronic Disease Management market be worth by 2035?

Chronic Disease Management market is expected to be worth of 37.14 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

How will the Chronic Disease Management market perform over the next 10 years?

Over the next 10 years the Chronic Disease Management market is expected to shift from usd billion 9.29 to 37.14 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2026 to 2035.

What was the market size of the Chronic Disease Management Market in 2025?

The Chronic Disease Management Market is expected to be valued at 22.92 USD Billion in 2025.

Which region is expected to dominate the Chronic Disease Management Market by 2035?

North America is expected to dominate the Chronic Disease Management Market with a projected value of 17.5 USD Billion by 2035.

What will be the market size for diabetes management in the Chronic Disease Management Market by 2035?

The market for diabetes management is projected to be valued at 10.0 USD Billion in 2035.

What is the projected market value for cardiovascular disease management by 2035?

The market value for cardiovascular disease management is expected to reach 12.0 USD Billion by 2035.

What are some of the major players in the Chronic Disease Management Market?

Key players in the market include Novartis, CVS Health, and UnitedHealth Group.

Research Approach

Research Methodology on Chronic Disease Management Market

Introduction

Chronic Disease Management (CDM) is an emerging trend in healthcare and is a set of integrated patient-oriented techniques and interventions that focus on critical health issues such as diabetes, heart disease, asthma, depression, and cancer. CDM strives to improve the quality of care for individuals with chronic diseases through active collaboration with healthcare providers, personalized care plans, and preventive care advocacy. The objective of this research project is to conduct a thorough analysis of the CDM market and provide a comprehensive overview of the various trends, challenges and opportunities in the global CDM market.

Research Objectives

  • To establish a comprehensive understanding of the global market for chronic disease management
  • To ascertain market segmentation and its impact on the growth of the CDM market
  • To analyze the current and emerging trends and their impact on the growth of the CDM market.
  • To identify and analyze key growth drivers and challenges in the CDM market
  • To scrutinize Porter’s Five Forces model of the CDM market and its impact on the growth of the CDM market.
  • To assess the competitive landscape of the CDM market by analyzing major players

 

Data Collection Methods

Two methods of data collection are planned for this research project – secondary research and primary research.

Secondary Research

Secondary research involves collecting external data from existing works such as research papers, and reports published by industry bodies, Government organizations, and other online sources. Secondary research datasets from reliable sources like Market Research Future (MRFR), Datamonitor, Research and Markets, and various industry journals. The sources cover multiple domains in the healthcare domain such as patient care, health technology and health administration.

Primary Research

Primary research comprises surveys, interviews, and focus group discussions. Data from primary research is obtained through both qualitative and quantitative research. A structured questionnaire is used to collect survey responses from actors in the CDM market. In addition, interviews with industry experts, analysts, and opinion leaders are conducted. Furthermore, focus group discussions with patients and healthcare professionals will be used to collect further information on the current CDM trends and challenges.

Sampling Method

A sampling process based on the survey respondents’ profiles is employed. The selection criteria are based on the knowledge and expertise of the survey participants in the areas of chronic disease management, healthcare delivery, and other related fields. The key criteria include their role in the CDM market, geographical location, ownership, type of organization and other requirements.

Sampling Size

The sample size is estimated to be 100. It is expected that the survey response rate will be approximately 50%. The sample size is adjusted based on the survey response rate after each round of the survey.

Data Analysis

Quantitative and qualitative analysis is used to analyze the primary research data. Coding and content analysis is used for open-ended survey questions. Frequency analysis is used to analyze quantitative survey responses.

Statistical Methods

Data analysis is conducted using advanced statistical techniques such as regression analysis, Hypothesis testing, ANOVA and Factor Analysis. These techniques are used to understand the market dynamics and uncover the various trends and challenges in the CDM market.

Reporting

The report is presented in an executive summary format and comprises key findings and recommendations. The report includes data and insights on the global market for Chronic Disease Management, trends and influences, and competitive outlook. In addition, the report includes a summary of the primary research findings and recommendations for further research.

Conclusion

The research project aims to explore the current trends in the global Chronic Disease Management Market. The report provides comprehensive insights into the drivers and challenges, market dynamics, and competitive landscape of the CDM market. The planned data collection and statistical analysis methods detailed in this research methodology are expected to provide a thorough understanding of the CDM market and its competitive environment.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓